Is the swine flu going to be pandemic?

...

For me, that last one is a no-brainer. My FEV1's are below thirty percent on a good day. If I require antiviral therapy, the one making the call will be ME.
If you think you can examine diagnose and prescribe for patients with flu symptoms because you read a lot about the flu, you are naive.

Tell me, what would you put on your differential for a patient with a fever, cough and headache that you saw in your imaginary clinic tomorrow, and how would you decide which thing on that list the patient had and what to prescribe for them?
 
Are you accusing the WHO and CDC of ignoring significant person-to-person transmission outside of the US, Mexico, and Canada?
No, they've got that sustained transmission on the list. The last update from the WHO downplayed the spread to the rest of the world and said we were not at level 6 yet. I had just read about the outbreak spreading in Spain.

But now there are a number of reports out saying declaration of level 6 pandemic is about to be made.
 
Oh, I've done plenty of that, but I don't see any of it helping me to understand just exactly what a subtype is....

Suppose we do confine it to a single species. Do you believe that, say, seasonal H1N1 and H3N2 have preferences for different receptors? Assuming that your answer is no, why the need for both the H1 and the H3? See what I mean? It can't be just about receptor binding specificity. Seems like it must have something to do with structures other than the binding sites. It drives me crazy.....
The nature of the hemagglutinin, sialic acids and receptor binding specificity was exactly what the paper I linked to explained. You are going around in circles with this question.

The problem isn't that no one can explain it. The problem is that you need to take the time to learn about these proteins from the bottom up. You want a simple explanation but then you say that explanation isn't good enough. But when I point you to a paper with the more complex explanation, you don't understand the paper.

Start with the Wiki pages below and get a better grasp of the basics then try tackling the next couple links below on hemagglutinin, then try the sialobiology paper again. If you won't take the time to understand the basics, you can't expect to understand the complexity of the virus.

OrthomyxoviridaeWP
The following applies for Influenza A viruses, although other influenza strains are very similar in structure[19]:

The influenza A virus particle or virion is 80-120 nm in diameter and usually roughly spherical, although filamentous forms can occur.[20] Unusually for a virus, the influenza A genome is not a single piece of nucleic acid; instead, it contains eight pieces of segmented negative-sense RNA (13.5 kilobases total), which encode 11 proteins (HA, NA, NP, M1, M2, NS1, NEP, PA, PB1, PB1-F2, PB2).[21] The best-characterised of these viral proteins are hemagglutinin and neuraminidase, two large glycoproteins found on the outside of the viral particles. Neuraminidase is an enzyme involved in the release of progeny virus from infected cells, by cleaving sugars that bind the mature viral particles. By contrast, hemagglutinin is a lectin that mediates binding of the virus to target cells and entry of the viral genome into the target cell.[22] The hemagglutinin (H) and neuraminidase (N) proteins are targets for antiviral drugs.[23] These proteins are also recognised by antibodies, i.e. they are antigens.[11] The responses of antibodies to these proteins are used to classify the different serotypes of influenza A viruses, hence the H and N in H5N1.

Hemagglutinin (influenza)WP

Bird Flu - Haemagglutinin

Hemagglutinin
 
If you think you can examine diagnose and prescribe for patients with flu symptoms because you read a lot about the flu, you are naive.
Yeah, diagnosing flu at the peak of flu season is real complicated. Best bet is to parade all of those symptoms through the nearest clinic before initiating any kind of treatment; more repeat customers, more money for public health infrastructure, everybody wins.

The nature of the hemagglutinin, sialic acids and receptor binding specificity was exactly what the paper I linked to explained.
Yes, I know. But it doesn't explicitly elucidate the basis for the subtype distinction, and since we've noted that receptor binding does not respect subtype boundaries, it doesn't make sense to me that it would be that.

The problem isn't that no one can explain it.
No, my problem is that I can't explain it.

If you won't take the time to understand the basics, you can't expect to understand the complexity of the virus.
I don't disagree (of course, those who have taken the time to absorb the advanced material seldom claim to "understand the complexity of the virus" either). The subtype distinction seems like it ought to be part of "the basics". Indeed, it has occurred to me that the reason I never find it in any of the advanced literature is that the matter is regarded as too trivial to mention. It's a lot of why it bugs me. So I go looking in the basic material, and can't find it there either. I'm willing to take the time to understand it. If you understand it, then instead of linking to more material that doesn't explain it (which I know because I've been through most of it already), I'd appreciate it if you'd take the time to explain it. Shouldn't take long. Is "receptor binding" your final answer? I mean, maybe that is it, and I'm just overthinking it.

The closest hint I can find in any of the stuff you linked is this quote from the last one:

"The specificity, and thus the danger, of each strain of influenza virus depends on the particular type hemagglutinin that it carries."

So the specificity depends on the type. Fine and dandy. Now: does the type depend on the specificity? Is the difference between a cow and a rattlesnake the fact that one eats grass and the other rodents? You could categorize critters based solely on food preferences if that were all you had to go by, but I think you'd want to acknowledge that there might be some other important differences you couldn't pick up by that method. See what I mean?
 
The subtypes (H1N1, H5N1 etc) were determined by serotyping, which means the HA proteins are recognised by antibodies. The protein sequences recognised by these antibodies are similar and now the viruses can be typed by RNA sequencing based on these shared regions.
 
The subtypes (H1N1, H5N1 etc) were determined by serotyping, which means the HA proteins are recognised by antibodies. The protein sequences recognised by these antibodies are similar and now the viruses can be typed by RNA sequencing based on these shared regions.
About time you showed up. I was thinking about paging you. Earlier, I asked whether the subtyping might be considered essentially an artifact of the methodology, or whether it was taxonomic. Not necessarily saying those two should be conisdered mutually exclusive. I mean, the epitopes of the antibodies we're talking about aren't necessarily at the actual binding sites the virus uses to bind to cells, right? So we say that those that respond to this antibody versus that one are of a certain type, and use this as a means of distinguishing them on a taxonomic (and presumably, a functional) basis. Am I warm?
 
About time you showed up. I was thinking about paging you. Earlier, I asked whether the subtyping might be considered essentially an artifact of the methodology, or whether it was taxonomic. Not necessarily saying those two should be conisdered mutually exclusive. I mean, the epitopes of the antibodies we're talking about aren't necessarily at the actual binding sites the virus uses to bind to cells, right? So we say that those that respond to this antibody versus that one are of a certain type, and use this as a means of distinguishing them on a taxonomic (and presumably, a functional) basis. Am I warm?
Yes, serotyping is just that, it types the viruses by antisera which obviously has a relevance for vaccine design. It's not necessarily related to the receptor binding sites (function).
 
Last edited:
Yes, serotyping is just that, it types the viruses by antisera which obviously has a relevance for vaccine design. It's not necessarily related to the receptor binding sites (function).
And, equally obvious, relevance for immune response whether an individual is vaccinated (or has pre-existing immunity from previous infection) or not. So, in a sense, it's essentially saying something like: "Here's a type that these particular antibodies bind to" (with an agreed-upon degree of affinity). Right?

One more, another repeat of an earlier question. Would we expect an H1 and an H3 to bind to the same receptors?
 
And, equally obvious, relevance for immune response whether an individual is vaccinated (or has pre-existing immunity from previous infection) or not. So, in a sense, it's essentially saying something like: "Here's a type that these particular antibodies bind to" (with an agreed-upon degree of affinity). Right?
Yes. Why do you mention affinity?

One more, another repeat of an earlier question. Would we expect an H1 and an H3 to bind to the same receptors?
Yes, but also changes to HA alter its receptor binding affinity, so a change in avian HA may render it able to infect human cells. Note that the vaccine/infection generates antibodies that block binding of HA to the sialic acid receptor.
 
Why do you mention affinity?
Well, evolutionary processes in general have deeply interested me for a long time. Affinity maturation is an evolutionary process within an evolutionary process, and therefore doubly fascinating. (Including the viral evolution makes the math more difficult; I can't decide whether to add or multiply). I don't understand nearly as much about it as I'd like to, but it's not for lack of trying. One of my favorite books on the subject is Immunology and Evolution of Infectious Disease by Stephen Frank (which is available free here. He discusses specificity and affinity maturation and cross-reactivity in some detail, and I gnawed on that stuff for quite a while.

If I understand correctly, affinity can be treated as both a gradient and a threshold (or a gradient above a certain minimum threshold). Where a natural encounter between pathogen and host occurs, the threshold is wherever the threshold is, but as far as laboratory testing goes, I have the impression that the threshold is basically a line drawn by whomever designed the protocols (I want to say "arbitrarily", but I'm sure that isn't quite the right word).
 
This thread reminds me why I love the JREF and always visit here first for informed and intelligent writing on current scientific issues.
 
Well, evolutionary processes in general have deeply interested me for a long time. Affinity maturation is an evolutionary process within an evolutionary process, and therefore doubly fascinating. (Including the viral evolution makes the math more difficult; I can't decide whether to add or multiply). I don't understand nearly as much about it as I'd like to, but it's not for lack of trying. One of my favorite books on the subject is Immunology and Evolution of Infectious Disease by Stephen Frank (which is available free here. He discusses specificity and affinity maturation and cross-reactivity in some detail, and I gnawed on that stuff for quite a while.

If I understand correctly, affinity can be treated as both a gradient and a threshold (or a gradient above a certain minimum threshold). Where a natural encounter between pathogen and host occurs, the threshold is wherever the threshold is, but as far as laboratory testing goes, I have the impression that the threshold is basically a line drawn by whomever designed the protocols (I want to say "arbitrarily", but I'm sure that isn't quite the right word).
I'm not quite sure which laboratory test you mean. For antisera where there are multiple antibodies for a specific antigen, then that is strictly called avidity. Affinity/avidity is not normally measured but rather the titre of an antibody which is the dilution at which a chosen level of binding is observed. The chosen level should be where there is a linear relationship between the antibody dilution and and binding.
 
Another US death.

http://www.google.com/hostednews/ap/article/ALeqM5hNkUqwzLRY-8nSc_6e5AM0Vf2FIgD9809L7G0

McALLEN, Texas (AP) — Texas health officials have confirmed the first death of a United States resident with swine flu.

Few details have been released, but officials say the flu victim was a woman who lived in Cameron County, along the U.S.-Mexico border, and had other, chronic health problems.

The Texas Department of State Health Services said Tuesday that she died earlier this week.

Last week, a boy from Mexico City died at a Houston hospital, marking the first swine flu death in the United States.
 
Yeah, diagnosing flu at the peak of flu season is real complicated. Best bet is to parade all of those symptoms through the nearest clinic before initiating any kind of treatment; more repeat customers, more money for public health infrastructure, everybody wins.
Afraid to put your (hypothetical) money where your mouth is I see. You left my second sentence out of the quote. Here, let me repeat it for you:
"Tell me, what would you put on your differential for a patient with a fever, cough and headache that you saw in your imaginary clinic tomorrow, and how would you decide which thing on that list the patient had and what to prescribe for them?"

Or is your answer, flu is the only thing on your list of what the patient has?

Yes, I know. But it doesn't explicitly elucidate the basis for the subtype distinction, and since we've noted that receptor binding does not respect subtype boundaries, it doesn't make sense to me that it would be that.

No, my problem is that I can't explain it.
You said, no one could explain it, and that, you had asked a number of people.

I don't disagree (of course, those who have taken the time to absorb the advanced material seldom claim to "understand the complexity of the virus" either). The subtype distinction seems like it ought to be part of "the basics". Indeed, it has occurred to me that the reason I never find it in any of the advanced literature is that the matter is regarded as too trivial to mention. It's a lot of why it bugs me. So I go looking in the basic material, and can't find it there either. I'm willing to take the time to understand it. If you understand it, then instead of linking to more material that doesn't explain it (which I know because I've been through most of it already), I'd appreciate it if you'd take the time to explain it. Shouldn't take long. Is "receptor binding" your final answer? I mean, maybe that is it, and I'm just overthinking it.
Or maybe it's that you didn't read the resources I gave you links to. You seem to be looking for a simple round peg in a simple round hole answer. It doesn't work that way. The complex organic molecules involved are not simple holes and pegs.

The closest hint I can find in any of the stuff you linked is this quote from the last one:

"The specificity, and thus the danger, of each strain of influenza virus depends on the particular type hemagglutinin that it carries."

So the specificity depends on the type. Fine and dandy. Now: does the type depend on the specificity? Is the difference between a cow and a rattlesnake the fact that one eats grass and the other rodents? You could categorize critters based solely on food preferences if that were all you had to go by, but I think you'd want to acknowledge that there might be some other important differences you couldn't pick up by that method. See what I mean?
Fess up. You didn't really look at the links, did you?
 
Tell me, what would you put on your differential for a patient with a fever, cough and headache that you saw in your imaginary clinic tomorrow, and how would you decide which thing on that list the patient had and what to prescribe for them?"
I'd let Ivor decide. I've got a full caseload just looking after myself.

You said, no one could explain it, and that, you had asked a number of people.
Read my posts again. There are a lot of things about influenza which no one understands, but I never stated nor implied that the basis for the subtype classification is one of them. The last time you tried to put those words in my mouth, my response was "No, my problem is that I can't explain it." I could overlook it as a simple misunderstanding the first time, but now you're just being outright disingenuous. This forum does feature a quote button, and I know you know how to use it.

Or maybe it's that you didn't read the resources I gave you links to.
You know, that might make a good sig.

You seem to be looking for a simple round peg in a simple round hole answer.
Actually, I've finally gotten an answer I think I can live with. When the pupil is ready and all that. Thanks for trying, tho.
 
Just as I thought, Dymanic, you denigrate the expertise it takes to diagnose a patient then cop out when challenged.

As for the hemagglutinin, something tells me you don't have a clue what Capsid is talking about, but whatever. Of course a discussion of the hemagglutinin antibody tests was thoroughly discussed in the first paper I gave you a link to on this.
 
Last edited:
I'd let Ivor decide.
Reminds me of something I once read right here on the forums, though I can't remember by whom: During a gastroenteritis epidemic, it is important for the doctor to rule out appendicitis in every case he sees because, if he sees enough cases, one of them will eventually turn out to have appendicitis.

Ivor would send that patient home to die of peritonitis.

BillyJoe
 

ISF - Join now!

Every member here is approved by hand. No bots, no spam, just people who care about evidence and honest debate.

Membership is free!

Create your free account

Back
Top Bottom